Clinical and bone marrow effects of α-interferon therapy in myelofibrosis with myeloid metaplasia.

被引:0
|
作者
Tefferi, A [1 ]
Elliott, MA [1 ]
Yoon, SY [1 ]
Li, CY [1 ]
Mesa, RA [1 ]
Call, TG [1 ]
Dispenzieri, A [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3222
引用
收藏
页码:745A / 745A
页数:1
相关论文
共 50 条
  • [1] Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia
    Tefferi, A
    Elliott, MA
    Yoon, SY
    Li, CY
    Mesa, RA
    Call, TG
    Dispenzieri, A
    BLOOD, 2001, 97 (06) : 1896 - 1896
  • [2] Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia
    Yoon, SY
    Li, CY
    Mesa, RA
    Tefferi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 682 - 688
  • [3] Bone marrow immunohistochemical studies of fibrogenic and angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
    Chou, JM
    Li, CY
    Tefferi, A
    BLOOD, 2002, 100 (11) : 590A - 590A
  • [4] Bone marrow histologic and cytogenetic changes during leukemic transformation of myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Li, CY
    Ketterling, RP
    Knudson, RA
    Tefferi, A
    BLOOD, 2004, 104 (11) : 271B - 271B
  • [5] Clinical correlates of splenic histopathology in myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Li, CY
    Schroeder, GS
    Tefferi, A
    BLOOD, 1999, 94 (10) : 115A - 115A
  • [6] Thalidomide in patients with myelofibrosis with myeloid metaplasia.
    Barosi, G
    Grossi, A
    Comotti, B
    Marchetti, M
    BLOOD, 2000, 96 (11) : 746A - 746A
  • [7] Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
    Tefferi, A
    Meyer, RG
    Wyatt, WA
    Dewald, GW
    BLOOD, 2000, 96 (11) : 746A - 746A
  • [8] Medical progress: Myelofibrosis with myeloid metaplasia.
    Tefferi, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (17): : 1255 - 1265
  • [9] Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia.
    Guardiola, P
    Esperou, H
    Cazals, D
    Ifrah, N
    Jouet, JP
    Buzyn, A
    Sutton, L
    Gratecos, N
    Tilly, H
    Lioure, B
    Gluckman, E
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 202 - 202
  • [10] Responses to thalidomide combined with prednisone therapy for myelofibrosis with myeloid metaplasia.
    Qian, Shenxian
    Tan, Junfeng
    Shi, Pengfei
    Gao, Gaqian
    BLOOD, 2006, 108 (11) : 1035A - 1035A